ALSSF (ALSSF) Stock Price & Analysis
ALSSF (ALSSF) rose 0.00% to USD 2.9 as of June 10, 2026 at 00:54 UTC, according to Nexqual real-time market data.
ALSSF last closed at USD 2.9; the session ranged USD 2.9–2.9 on volume of 100 shares. Market capitalization is $2.31B, with a 52-week range of USD 2.48–3.69 (PNK). Source: Nexqual, June 10, 2026 at 00:54 UTC.
Key Statistics (as of June 10, 2026 at 00:54 UTC)
| Price | USD 2.9 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 2.9 |
| Open | USD 2.9 |
| Day Range | USD 2.9 – 2.9 |
| 52-Week Range | USD 2.48 – 3.69 |
| Volume | 100 shares |
| Market Cap | $2.31B |
| Exchange | PNK |
Technical Analysis (ALSSF)
Nexqual's technical model rates ALSSF "SELL" based on 1 bullish and 5 bearish signals across 123 daily candles, as of June 10, 2026 at 00:54 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 3.01 (oversold) |
| vs SMA50 | Below (USD 3.03) |
| MACD | -0.04 (negative) |
Analyst Ratings (ALSSF)
Wall Street analysts rate ALSSF "None", per Nexqual as of June 10, 2026 at 00:54 UTC.
| Consensus Rating | None |
|---|
Earnings (ALSSF)
| Next Earnings Date | 2026-07-21 |
|---|---|
| Revenue Estimate | $22.18B |
Source: Nexqual, June 10, 2026 at 00:54 UTC.
Financials & Fundamentals (ALSSF)
| Total Revenue | $85.43B |
|---|---|
| Revenue Growth (YoY) | +0.30% |
| Gross Margin | +34.85% |
| Operating Margin | +8.15% |
| Profit Margin | +2.45% |
| ROE | +25.39% |
| Debt / Equity | 574.8 |
| Current Ratio | 0.56 |
| Total Cash | $5.25B |
| Total Debt | $51.61B |
| Free Cash Flow | $6.14B |
Source: Nexqual, June 10, 2026 at 00:54 UTC.
Financial Health Score (ALSSF)
Nexqual rates ALSSF's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 00:54 UTC.
| Growth | Solid — Revenue +7% YoY (annual) |
|---|---|
| Profitability | Solid — Gross margin 35%, operating 8% |
| Balance Sheet | Critical — $5.25B cash vs $51.6B debt |
| Cash Flow | Solid — FCF $6.14B, 7% margin |
| Efficiency | Strong — ROE 25%, ROA 6.6% |
Ownership (ALSSF)
| Insider Ownership | +39.69% |
|---|---|
| Institutional Ownership | +25.00% |
| Shares Outstanding | 797.42M |
| Float | 433.80M |
Source: Nexqual, June 10, 2026 at 00:54 UTC.
Leadership (ALSSF)
ALSSF is led by Christian Gurria Dubernard, Chief Executive Officer, per Nexqual as of June 10, 2026 at 00:54 UTC.
| Chief Executive Officer | Christian Gurria Dubernard |
|---|---|
| Chairman & President | Armando Torrado Martinez (age 56) |
| Founder & Director | Alberto Torrado Martinez (age 62) |
| CFO and Director of Administration & Finance | Engineer Federico Rodríguez Rovira (age 44) |
| Investor Relations & Corporate Affairs Director | Gerardo Lozoya Lapati |
Major Backers & Investors (ALSSF)
Notable institutional backers of ALSSF include DFA INVESTMENT DIMENSIONS GROUP INC-Emerging Markets Core Eqy. 2 PORT., American Century ETF Trust-Avantis Emerging Markets Equity ETF, MEXICO FUND INC, according to Nexqual as of June 10, 2026 at 00:54 UTC.
Active Investors
| Investor | Stake |
|---|---|
| DFA INVESTMENT DIMENSIONS GROUP INC-Emerging Markets Core Eqy. 2 PORT. | 0.53% |
| American Century ETF Trust-Avantis Emerging Markets Equity ETF | 0.22% |
| MEXICO FUND INC | 0.21% |
| Schwartz Investment Trust-Ave Maria World Equity Fund | 0.11% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 1.91% |
| BlackRock | 1.59% |
Source: Nexqual, June 10, 2026 at 00:54 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| TPZEF | TOPAZ ENERGY CORP. | USD 23.06 | ▼ 3.12% |
| BFFAF | BASF SE | USD 61.5 | ▲ 7.12% |
| AIMFF | Aimia, Inc. | USD 2.01 | ▼ 0.99% |
| ACXIF | Acciona S.A. | USD 280 | ▼ 5.41% |
| ALPMF | Astellas Pharma, Inc. | USD 14.26 | ▲ 0.42% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 00:54 UTC. This page is informational and not investment advice.